Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Xynomic Received China Approval to Start 2 Pivotal Lymphoma Clinical Trials

Wednesday, July 31, 2019

Xynomic Pharmaceuticals Holdings Inc Xynomic stock ticker XYNO a clinical stage USChina oncology drug development company announced that Xynomic has received approval from Chinas National Medical Products Administration NMPA to start two pivotal clin...

U.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer (nmCRPC)

Wednesday, July 31, 2019

US FDA approves darolutamide a new treatment for men with nonmetastatic castrationresistant prostate cancer nmCRPC

CANbridge Pharmaceuticals Submits New Drug Application for Hunterase® for the Treatment of Hunter Syndrome in China

Tuesday, July 30, 2019

CANbridge Pharmaceuticals Inc a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets announced that it has filed a New Drug Application NDA with the National Medical Produc...

Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome

Tuesday, July 30, 2019

Orchard Therapeutics a leading commercialstage biopharmaceutical company dedicated to transforming the lives of patients with serious and lifethreatening rare diseases through innovative gene therapies today announced that it has received Regenerativ...

Alexion Receives Positive CHMP Opinion for SOLIRIS® (eculizumab) for the Treatment of NMOSD

Monday, July 29, 2019

Alexion Pharmaceuticals Inc announced that the European Medicines Agency EMA Committee for Medicinal Products for Human Use CHMP has issued a positive opinion to extend the current marketing authorization of SOLIRIS eculizumab to include the treatmen...

Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia

Friday, July 26, 2019

Mustang Bio Inc a clinicalstage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers solid tumors and rare genetic diseases today announced that the US F...

Pelican BioThermalReveals 2019 Biopharma Cold Chain Logistics Survey Insights Amid Surge of Temperature-Controlled Products

Friday, July 26, 2019

Pelican BioThermal the global name in temperaturecontrolled packaging surveyed key opinion leaders in the biopharmaceutical industry to better understand emerging cold chain challenges The Biopharma Cold Chain Logistics Survey report details compell...

Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome

Friday, July 26, 2019

Arena Pharmaceuticals Inc today announced that the first subject has been dosed in the Phase CAPTIVATE trial evaluating olorinab an investigational oral highlyselective full agonist of the cannabinoid type receptor CB in development for the treatme...

Dubai to Host Dubai Conference & Exhibition this November

Thursday, July 25, 2019

Dubai is set to host the th edition of the Dubai Otology Neurotology and Skull Base Surgery Conference Exhibition Dubai Otology from November at Mohammed Bin Rashid Academic Medical Center Dubai Healthcare City

Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia

Thursday, July 25, 2019

Kura Oncology Inc a clinicalstage biopharmaceutical company focused on the development of precision medicines for oncology today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to the Companys meninmixed lin...